A new drug reduces risk of psychosis relapse in patients with dementia
Read now →Pimavanserin has not received approval from the FDA, but study results are encouraging
Soren Emerson
Neuroscience
Vanderbilt University
Soren Emerson is a an entering first year PhD student in the Vanderbilt University neuroscience program. He previously attended, and graduated from, Davidson College with a B.S. in neuroscience. He conducted three years of independent research at Davidson College under the mentorship of Dr. Mark Smith, a behavioral pharmacologist, and Dr. Rachid El Bejjani, a C. elegans neurobiologist. His research modeled the genetic and molecular mechanism of cocaine in C. elegans and the results of the project yielded a first author publication. At Vanderbilt, Soren plans to continue his research career in neuropharmacology.
Psilocybin reduced depression symptoms as much as a leading antidepressant
Read now →New research compared the "magic mushrooms" component to Lexapro
What nematodes laying eggs tells us about how cocaine affects the brain
Read now →New research uncovers a link between cocaine and acetylcholine that could eventually lead to new treatments for addiction
Drug overdose deaths in the US jumped nearly 30 percent in 2020
Read now →The story behind these numbers is complex, but opioids have played a major role
Laughing gas could be the next tool against treatment-resistant depression
Read now →A small clinical trial shows promise for people who don't find relief from antidepressants
Drinking way, way too much coffee might shrink your brain
Read now →Up to five cups of coffee per day seems to be fine. Six or more? Your brain is going to feel it
New machine learning approach can identify your circadian rhythm from a blood sample
Read now →Doctors do not currently monitor a person's circadian rhythms because there is not an efficient way to measure them
.jpeg?auto=compress%2Cformat&crop=faces&fit=crop&fm=jpg&h=800&q=70&w=1200)
Tapering off opioids is treacherous for mental health
Read now →A large-scale study shows how the opioid epidemic has created downstream negative health outcomes
Modified tree resins prevent zebrafish from having seizures
Read now →Could these resins also be used to treat epilepsy in humans?
Could blockchain technology protect patients from counterfeit medication?
Read now →Not so fast. We should be wary of trying to science our way out of large-scale health issues
2 peer comments
New drug addresses long overlooked "negative" symptoms of schizophrenia
Read now →A data-driven search found a compound that shows promising results in early trials
3 peer comments
We must reckon with our ableism if we want healthcare to work for people
Read now →People who had COVID-19 may need long-term care — the US healthcare system isn't ready
6 peer comments
.jpeg?auto=compress%2Cformat&crop=faces&fit=crop&fm=jpg&h=360&q=70&w=540
)
The lab-leak hypothesis for COVID-19 is becoming a conspiracy theory
Read now →To explain where SARS-CoV-2 came from, look at processes with scientific explanations and precedents
5 peer comments